HK6385A - Xanthine derivatives having antiallergic activity and pharmacological preparations containing them - Google Patents

Xanthine derivatives having antiallergic activity and pharmacological preparations containing them

Info

Publication number
HK6385A
HK6385A HK63/85A HK6385A HK6385A HK 6385 A HK6385 A HK 6385A HK 63/85 A HK63/85 A HK 63/85A HK 6385 A HK6385 A HK 6385A HK 6385 A HK6385 A HK 6385A
Authority
HK
Hong Kong
Prior art keywords
preparations containing
xanthine derivatives
antiallergic activity
pharmacological preparations
pharmacological
Prior art date
Application number
HK63/85A
Other languages
English (en)
Inventor
Sten Hakan Axel Mag Bergstrand
Per Gunnar Kjellin
Carl Goeran August Persson
Lars Magnus Soerenby
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of HK6385A publication Critical patent/HK6385A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK63/85A 1977-10-14 1985-01-24 Xanthine derivatives having antiallergic activity and pharmacological preparations containing them HK6385A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (1)

Publication Number Publication Date
HK6385A true HK6385A (en) 1985-02-01

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
HK63/85A HK6385A (en) 1977-10-14 1985-01-24 Xanthine derivatives having antiallergic activity and pharmacological preparations containing them

Country Status (21)

Country Link
US (1) US4233303A (fi)
EP (1) EP0001735B1 (fi)
JP (1) JPS5479296A (fi)
AT (1) AT363491B (fi)
AU (1) AU521585B2 (fi)
CA (1) CA1109470A (fi)
CS (1) CS208756B2 (fi)
DD (1) DD139855A5 (fi)
DE (1) DE2862017D1 (fi)
DK (1) DK148260C (fi)
FI (1) FI66383C (fi)
HK (1) HK6385A (fi)
HU (1) HU180219B (fi)
IE (1) IE47884B1 (fi)
IT (1) IT1109208B (fi)
NO (1) NO147562C (fi)
NZ (1) NZ188566A (fi)
SE (1) SE416810C (fi)
SG (1) SG85584G (fi)
SU (1) SU755199A3 (fi)
ZA (1) ZA785335B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU4527896A (en) * 1994-12-13 1996-07-03 Euro-Celtique S.A. Aryl thioxanthines
ATE247655T1 (de) * 1994-12-13 2003-09-15 Euro Celtique Sa Dreifachsubstituierte thioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
NZ543109A (en) 2003-04-25 2008-06-30 Novacardia Inc Method of improved diuresis in individuals with impaired renal function
US20050239759A1 (en) * 2004-04-16 2005-10-27 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
DE2862017D1 (en) 1982-10-28
SE416810C (sv) 1982-07-19
HU180219B (en) 1983-02-28
SE416810B (sv) 1981-02-09
FI66383B (fi) 1984-06-29
US4233303A (en) 1980-11-11
CS208756B2 (en) 1981-09-15
DD139855A5 (de) 1980-01-23
NO147562B (no) 1983-01-24
FI66383C (fi) 1984-10-10
CA1109470A (en) 1981-09-22
EP0001735A1 (en) 1979-05-02
SG85584G (en) 1985-06-07
IE47884B1 (en) 1984-07-11
IE782041L (en) 1979-04-14
AT363491B (de) 1981-08-10
DK148260B (da) 1985-05-20
JPS5479296A (en) 1979-06-25
AU4036578A (en) 1980-04-17
IT1109208B (it) 1985-12-16
DK453778A (da) 1979-04-15
IT7851499A0 (it) 1978-10-13
ZA785335B (en) 1979-09-26
SE7711581L (sv) 1979-04-15
NO783471L (no) 1979-04-18
EP0001735B1 (en) 1982-09-01
ATA714478A (de) 1980-09-15
FI783126A (fi) 1979-04-15
DK148260C (da) 1986-02-10
NO147562C (no) 1983-05-18
NZ188566A (en) 1984-07-06
SU755199A3 (en) 1980-08-07
AU521585B2 (en) 1982-04-22

Similar Documents

Publication Publication Date Title
DE2862017D1 (en) Xanthine derivatives having antiallergic activity and pharmacological preparations containing them
PH13973A (en) Cyclosporin derivatives and pharmaceutical compositions-containing them
NZ188151A (en) Triphenylalkene derivatives and pharmaceutical compostions
JPS5446754A (en) Benzhydrylguanidine derivatives and their use
GB2022073B (en) Derivatives of 5-nitro-imidazole with anti-protozoic activity
NZ183859A (en) Basically substituted xanthine derivatives and medicaments containing them
GB2001630A (en) Inosadiamine derivatives and their preparation
IL61261A0 (en) Pyridine and pyrimidine derivatives
ZA781598B (en) 4-alkylthio-2-trifluoromethylalkanesulfonanilides and derivatives thereof
PT67585B (en) Azacycloalkanes azacycloalkenes and derivatives thereof
GB2055370B (en) Ergol-8-ene and ergoline derivatives
NZ184158A (en) Uracil derivatives: preparation and pharmaceutical preparations
IL54013A0 (en) Everninomicin derivatives and their preparation
ZA783830B (en) Benzamidine derivatives
ZA806180B (en) Myocardium-protecting pyridine derivatives having an anti-arrhythmic activity and an activity as blood-platelets antiaggregants
GB2000776B (en) Tunicamine derivatives and their preparation
CY1170A (en) Pyrimidone and thiopyrimidone derivatives
JPS5448753A (en) Digoxigenine derivatives and manufacture
IL53859A (en) Dioxatricyclodecane derivatives and their preparation
DE3062034D1 (en) Adenine derivatives possessing pharmacological activity
CY1244A (en) Pyrimidone and thiopyrimidone derivatives
GB2005677B (en) Cyclopentano (b) furan derivatives and preperation and use thereof
GB2010245B (en) Rifamycin derivatives and their preparation
GB2007648B (en) Benzylideneaniline and its derivatives
ZA78455B (en) Therapeutically useful cysteinol and homocysteinol derivatives